OPKO Health, Inc. (TLV:OPK)

Market Cap	3.36B
Revenue (ttm)	2.13B
Net Income (ttm)	-597.31M
Shares Out	n/a
EPS (ttm)	-0.82
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,492,563
Average Volume	803,849
Open	439.90
Previous Close	439.00
Day's Range	434.00 - 444.40
52-Week Range	402.00 - 734.40
Beta	1.34
RSI	34.88
Earnings Date	Oct 29, 2025

About OPKO Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 2,997
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: OPK

Financial Performance

In 2024, OPKO Health's revenue was $713.14 million, a decrease of -17.41% compared to the previous year's $863.50 million. Losses were -$53.22 million, -71.82% less than in 2023.

Financial numbers in USD